Detalhe da pesquisa
1.
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.
Clin Infect Dis
; 72(1): 50-60, 2021 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900486